Posted on July 21, 20257/21/25
Empowering Scientific Dialogue: Key Takeaways from the FDA’s SIUU Guidance
Posted on July 3, 20257/3/25
Staying Ahead of the Curve in Pharmacovigilance: Inspection Metrics Report for 2023 by Egyptian Drug Authority (EDA)
Posted on July 1, 20257/1/25
Staying Ahead of the Curve in Pharmacovigilance: ANVISA RDC No. 967/25
Posted on May 29, 20255/29/25
Navigating the Final FDA SIUU Guidance: Strategic Considerations for Scientific Exchange at ASCO and Other Congresses
Posted on May 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: CIOMS XIV Draft “Artificial Intelligence in Pharmacovigilance”
Posted on May 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: Outcome of GVP Inspections by NPRA
Posted on May 5, 20255/5/25
Staying Ahead of the Curve in Pharmacovigilance: Emerging Regulations and Their Implications in Saudi Arabia
Posted on June 28, 20246/28/24